scispace - formally typeset
C

Claudio Alarcón

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  12
Citations -  4183

Claudio Alarcón is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: SMAD & Transcription factor. The author has an hindex of 9, co-authored 9 publications receiving 3977 citations.

Papers
More filters
Journal ArticleDOI

Endogenous human microRNAs that suppress breast cancer metastasis

TL;DR: It is shown that restoring the expression of these microRNAs in malignant cells suppresses lung and bone metastasis by human cancer cells in vivo, and miR-126 restoration reduces overall tumour growth and proliferation, whereasmiR-335 inhibits metastatic cell invasion.
Journal ArticleDOI

Balancing BMP Signaling through Integrated Inputs into the Smad1 Linker

TL;DR: It is shown that linker phosphorylation restricts Smad1 activity by enabling Smad2 recognition by the HECT-domain ubiquitin ligase Smurf1, and the interplay between linkerosphorylation, Smirf-dependent ubiquitination, and nucleoporin exclusion enables regulation of BMP action by diverse signals and biological contexts.
Journal ArticleDOI

Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.

TL;DR: Previously identified as a regulator of renal sodium channels, Nedd4L is shown here to play a broader role as a general modulator of Smad turnover during TGF-beta signal transduction.
Journal ArticleDOI

C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells

TL;DR: It is suggested that C/EBPbeta plays a key role in the coordination of TGFbeta cytostatic gene responses, and its malfunction may trigger evasion of these responses in breast cancer.